Skip to main content
Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.41
+0.10 (0.88%)
Nov 21, 2024, 2:09 PM EST - Market open

Stoke Therapeutics Revenue

Stoke Therapeutics had revenue of $4.89M in the quarter ending September 30, 2024, with 47.94% growth. This brings the company's revenue in the last twelve months to $16.74M, up 81.08% year-over-year. In the year 2023, Stoke Therapeutics had annual revenue of $8.78M, down -29.22%.

Revenue (ttm)
$16.74M
Revenue Growth
+81.08%
P/S Ratio
34.44
Revenue / Employee
$152,209
Employees
110
Market Cap
604.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.78M-3.63M-29.22%
Dec 31, 202212.41M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 5.59B
Ironwood Pharmaceuticals 378.42M
Definitive Healthcare 255.85M
Entrada Therapeutics 215.23M
Phathom Pharmaceuticals 26.27M
Exscientia 22.88M
Oculis Holding AG 1.03M
Revenue Rankings

STOK News

More News